Delivery Order SPE2DB22D2009-SPE2DB26FL5ZP
Award Date 10/27/25
Potential Completion Date 10/28/25
Potential Value $3.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $69,305.82 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml syringes on May 27, 2025, with completion scheduled for May 28, 2025. This firm fixed price contract represents a non-competitive set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication commonly prescribed for severe asthma, eczema, and other inflammatory conditions, making this delivery order...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,756.97 for Dupixent 300 mg/2 mL syringes on October 21, 2025, with an ultimate completion date of October 22, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dupixent is a biologic medication used to treat conditions including asthma, eczema, and chronic...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for Dupixent 200mg/1.14ml syringes totaling $11,966.22 under a firm fixed price contract. This competitively awarded, non-set-aside delivery order is scheduled for completion by August 15, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used to treat...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $29,860.78 for Dupixent 300 mg/2 ml syringes on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price contract, which is not set-aside, will be performed at the company's corporate office in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used to treat moderate-to-severe atopic dermatitis, asthma, and other inflammatory conditions, making...
- The Defense Logistics Agency awarded a $31,152.11 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Dupixent 200 mg/1.14 mL syringes with a completion date of August 5, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Dupixent 300 mg/2 ml syringes with a ceiling value of $6,837.84. This delivery order represents a firm fixed price contract with no set-aside designation, meaning it was competitively awarded. The order is scheduled for completion by August 1, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Dupixent is a biologic medication...
- The Defense Logistics Agency awarded a delivery order valued at $53,846.79 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL syringes on September 15, 2025, with an ultimate completion date of September 16, 2025. This competitive award, which utilized firm fixed price contracting with no set-aside designation, represents a single delivery order transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a $13,593.94 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Dupixent 300 mg/2 mL syringes. This firm fixed-price, non-set-aside contract is classified as a delivery order with an ultimate completion date of September 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication primarily used to treat moderate-to-severe...
- The Defense Logistics Agency awarded a delivery order valued at $45,626.04 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL syringes on August 18, 2025, with completion scheduled for August 19, 2025. This firm fixed price contract represents a non-competitive delivery order issued under an existing contract vehicle and will be performed at the vendor's Conshohocken, Pennsylvania location. Dupixent is a biologic medication used to treat eczema, asthma, and other...
- The Defense Logistics Agency awarded a delivery order valued at $91,492.20 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL syringes on September 13, 2025, with an ultimate completion date of September 15, 2025. This competitively awarded, firm fixed price contract includes no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Dupixent is a biologic medication used to treat various inflammatory conditions...